A physician-scientist at a tertiary care clinic is designing a prospective trial to compare the efficacy of two different basal insulin regimens in patients with poorly controlled type 2 diabetes. The initial statistical analysis plan defines the primary endpoint as the absolute reduction in hemoglobin A1c (HbA1c), measured as a continuous variable. A preliminary sample size calculation indicates that patients are required to detect a clinically significant mean difference of between the groups with power and a two-sided of .
During a peer-review meeting, a colleague suggests altering the primary endpoint to a dichotomous outcome: the proportion of patients who successfully achieve an HbA1c of by the end of the observation period.
If this modification is adopted and the total sample size remains fixed at patients, which of the following is the most likely statistical consequence?
- The probability of failing to reject a false null hypothesis will increase.Answer
- BThe required inferential analysis will change to an analysis of variance (ANOVA).
- CThe modification will introduce effect modification, necessitating a stratified analysis.
- DThe positive predictive value of the statistical test will artificially increase.
- EThe interpretation of borderline results will become highly susceptible to anchoring bias.